Yujie Zhao
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Clonal origins and divergent evolutionary relationships of synchronous multiple malignant neoplasms in gynecology revealed by next-generation sequencing.
Journal: Cancer treatment and research communications
Published: August 17, 2025
The regulatory MaIAA1-like-MaERF003 module modulates the ripening of "Fenjiao" bananas.
Journal: Plant physiology
Published: February 20, 2025
Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early-stage lung adenocarcinoma.
Journal: Clinical and translational medicine
Published: January 14, 2025
Effects of Enterococcus faecalis Supplementation on Growth Performance, Hepatic Lipid Metabolism, and mRNA Expression of Lipid Metabolism Genes and Intestinal Flora in Geese.
Journal: Animals : an open access journal from MDPI
Published: December 15, 2024
Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study.
Journal: Signal transduction and targeted therapy
Published: October 28, 2024
Effects of dietary Artemisia annua supplementation on growth performance, antioxidant capacity, immune function, and gut microbiota of geese.
Journal: Poultry science
Published: January 14, 2024
Cervical cancer-specific long non-coding RNA landscape reveals the favorable prognosis predictive performance of an ion-channel-related signature model.
Journal: Cancer medicine
Published: October 23, 2023
A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
Journal: Current medicinal chemistry
Published: September 27, 2023
Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation.
Journal: Current medicinal chemistry
Published: September 06, 2023
Identifying Luteolin as a Potential Drug for Treating Lung Adenocarcinoma with COVID-19 Affection based on Integration Analysis of Pharmacology and Transcriptome.
Journal: Current medicinal chemistry
Published: May 31, 2023
Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma.
Journal: Frontiers in genetics
Published: February 01, 2023
Last Updated: 09/26/2026